Unmistakably
BD Oncology





Pharmacist

As a pharmacist, you know the importance of ensuring that each and every patient gets the right drug at the right time. With staff shortages and increasing demand for cytotoxic drugs1, you and your department need to streamline processes that can reduce errors in prescribing and compounding and so improve patient safety.

Our advanced system helps to reduce the risk of errors, reduce compounding times and improve inventory management. This in turn can also remove the need to remake doses, reduces drug waste and so cut costs too.

Unmistakably BD Oncology.

FOLLOW OUR PHARMACIST TO SEE HOW BD ONCOLOGY MAKES COMPOUNDING CHEMOTHERAPY PRESCRIPTIONS SAFER AND MORE EFFICIENT FOR BOTH STAFF AND PATIENTS


Relive ONCOLOGY LIVE #1: IV automated compounding during COVID: a European pharmacy perspective

During the first Oncology Live webinar, our three key opinion leaders from the United Kingdom, Germany and the Netherlands discussed how IV automation has aided them during COVID-19 and the similarities in their respective experiences.
The discussion also covered findings published in European Journal of Hospital Pharmacy, and concluded with questions posed by the audience.

Anna de Goede
Hospital Pharmacist, Qualified Person for Advanced Therapy Medicinal Products (ATMPs)

Radboud University Medical Center, Nijmegen, Netherlands

Professor Inderjit Singh
Chief Pharmacist

University Hospital Birmingham NHS Foundation Trust, United Kingdom

Professor Irene Krämer
Director of Pharmacy and Professor of Clinical Pharmacy

University Medical Center, Johannes Gutenberg-University, Mainz, Germany


Contact us